The Biotech Investor's Bible - libri usati

EAN (ISBN-13): 9780471412793
ISBN (ISBN-10): 0471412791
Copertina rigida
Anno di pubblicazione: 2001
Editore: John Wiley & Sons Inc
320 Pagine
Peso: 0,662 kg
Lingua: eng/Englisch

Libro nella banca dati dal 2007-04-07T11:30:51+02:00 (Zurich)
Pagina di dettaglio ultima modifica in 2024-04-01T22:15:45+02:00 (Zurich)
ISBN/EAN: 0471412791

ISBN - Stili di scrittura alternativi:
0-471-41279-1, 978-0-471-41279-3
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : georg wolff, verschiedene, john wolff, george white
Titolo del libro: biotech, the investors bible, 2001, george

---

Dati dell'editore

Autore: George Wolff
Titolo: The Biotech Investor's Bible
Editore: John Wiley & Sons
322 Pagine
Anno di pubblicazione: 2001-06-29
Peso: 0,575 kg
Lingua: Inglese
44,90 € (DE)
163mm x 238mm x 28mm

BB; gebunden; Hardcover, Softcover / Wirtschaft/Betriebswirtschaft; Anlagen und Wertpapiere; Finance & Investments; Finanz- u. Anlagewesen; Wirtschaft / Einz. Wirtschaftszweige, Branchen; Kapitalanlagen u. Wertpapiere; Investments & Securities; Kapitalanlagen u. Wertpapiere

Like the industry itself, the fundamentals of biotech investing are unique. Because the financial characteristics of biotechnology investments are unlike those of any other sector on the market, few analysts and investors predicted the industry's recent, dramatic gains and even fewer profited from it. The Biotech Investor's Bible is a practical guide to the essentials of biotechnology investment. Along with the most promising investing strategies, George Wolff provides an overview of an industry that many observers expect to emerge over the next century as the largest and most important business sector in the world. Wolff first focuses on the unique financial forces that drive biotech markets. With this approach, you'll gain a better understanding of the structure of the industry and its many processes, setting the stage for an analysis of sensible investment criteria. He then simplifies complex scientific concepts and technical terminology so you can quickly cut through industry jargon and make informed investment decisions. To help you get in as close as pos-sible on biotech's ground floor, Wolff prepares you with: * Guidelines and commonsense methods for picking companies * Details on new technologies and innovations * Advice on how to pick lesser known companies with unrealized value * Insights on how to structure a biotech portfolio * A breakdown of 185 major biotech companies Today, more than five thousand companies are engaged in the development of biotechnology worldwide. The work they do will fundamentally change life in this century, and every investor has a vested interest in knowing how the next industrial revolution will affect their holdings. No sector, from oil to insurance, from mining to medicine, will remain untouched.